<DOC>
	<DOCNO>NCT02607592</DOCNO>
	<brief_summary>The purpose study investigate overall toxicity value（OTV） , PFS , ORR OS advance adenocarcinoma treat nadaplatin cisplatin combine pemetrexed .</brief_summary>
	<brief_title>A Prospective Multi-center Phase III Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1 . Patient confirm primary adenocarcinoma pathologic histology cytology 2 . The TNM staging system accord IASLC2009 stageIV stageIIIB fit operation radiotherapy 3 . Including one available evaluation lesion least accord RECIST criterion 4 . Adult patient ( ≥18 year ≤75 year ) . ECOG Performance Status 0 1 .Life expectancy least 12 weeks.Haemoglobin ≥90g/dl , Absolute neutrophil count ( ANC ) ≥ 2x 109/L , platelet ≥100 x 109/L . Total bilirubin ≤upper limit normal ( ULN ) . ALT AST ≤ 2.5 x ULN . Creatinine clearance ≥60ml/min ( calculate accord Cockcroftgault formula ) . 5 . Patients never receive antineoplastic therapy 1 . Patient another cancer recent 5 year , include basal cell carcinoma cervical carcinoma situ 2 . Patient brain metastasis whose intracranial pressure symptom control use glucocorticoid mannitol 3 . Previous radiotherapy（Palliative radiotherapy order pain management excluded） 4 . Patient use chemotherapy ( bisphosphonate exclude ) 5 . Serious uncontrolled systemic disease include active infection , uncontrolled hypertension , diabetes , unstable angina , congestive heart failure , myocardial infarction , severe arrhythmia need drug , hepatic、renal metabolic disease 6 . Patient allergic drug need use 7 . Patients pregnancy lactation 8 . AST ALT 》2.5 * upper limit normal ( ULN ) ，and ALP》5*ULN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Non-Small-Cell Lung cancer</keyword>
	<keyword>overall toxicity value</keyword>
</DOC>